| INTC |
Report |
Revenue (Q2 2026) |
BEAT |
pred ~$14.70B vs. cons $14.43B (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Report |
Non-GAAP Gross Margin (Q2 2026) |
BEAT |
pred ~40.5% vs. cons 39.2% (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Report |
Non-GAAP EPS (Q2 2026) |
BEAT |
pred ~$0.27 vs. cons $0.223 (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Guide |
Revenue (Q3 2026) |
BETTER |
guide ~$15.5B vs. cons $15.115B (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Guide |
Non-GAAP EPS (Q3 2026) |
BETTER |
guide ~$0.30 vs. cons $0.279 (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Guide |
FY 2026 Revenue |
BETTER |
guide ~$60.5B vs. cons $58.892B (VA, Jul 22 2026) |
MEDIUM |
| INTC |
Guide |
Non-GAAP Gross Margin (Q3 2026) |
LOWER |
guide ~39.5% vs. cons ~40.3% (implied VA, Jul 22 2026) |
LOW |
| INTC |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.0% |
— |
MEDIUM |
| INTC |
Return |
5-day cumulative residual |
+8.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Q3/FY estimate revisions up; GM friction limits magnitude vs. Q1 2026 outlier |
LOW |